FDA Releases Draft Guidance on Premarket Approval Applications Review Process

Summary

The Food and Drug Administration (FDA) has made available a draft guidance document aimed at improving the review and inspection process for premarket approval applications under the Bioresearch Monitoring Program, in line with a performance goal set by the Medical Device User Fee and Modernization Act of 2002.